text

Novartis shells out $8.7 billion to buy AveXis

Novartis(NOVN.S)saidonMondayitplanstobuyAveXis(AVXS.O)for$218pershareinacashdealtotaling$8.7billionastheSwissdrugmakeraddsacompanywhosetopdrughopeful,forspinalm

text

GSK buys out Novartis in $13 billion consumer healthcare shake-up

GlaxoSmithKlineisbuyingNovartisoutoftheirconsumerhealthcarejointventurefor$13billion,takingfullcontrolofproductsincludingSensodynetoothpaste,Panadolheadachetabl